Abstract: An efficient and high yield method for the synthesis of aminobenzylated Mannich bases is described. The synthesis occurs in aqueous medium at 0 ºC. The compounds show moderate antitubercular and antimicrobial activities.
INTRODUCTION
Compounds containing active hydrogen atoms yielded aminobenzylated Mannich bases with secondary amines and aromatic aldehydes. Mannich bases are important compounds owing to their wide range of biological and industrial applications. They are also employed as intermediates 1, 2 in chemical synthesis and polymer chemistry. Several important therapeutic compounds have been synthesized via the Mannich reaction. [3] [4] [5] [6] They have also been found to possess pharmacological activities, such as antihypertensive, 7 antipsychotic, 8 anaesthetic, 9 antitubercular, 10 etc.
The starting 3-phenoxybenzaldehyde in reaction with cyclic secondary amines, such as piperidine, morpholine, indole and N-methylpiperazine, gives rise to intermediate N-cyclic phenyl carbinols, which on condensation with active hydrogen compounds, such as acetamide, urea and thiourea, yield Mannich bases (1-3) (Scheme 1).
The structures of the synthesized compounds were assigned on the basis of elemental analyses, FTIR, 1 H-NMR and MS spectral data. The compounds were screened for their in vitro antitubercular and antimicrobial activity.
EXPERIMENTAL
Thin layer chromatography was used to monitor the reactions and the purity of the synthesized compounds. The melting points were determined in open capillary tubes and are uncorrected. The IR spectra were recorded on a Shimadzu FTIR-8400 instrument using the KBr disc technique and only noteworthy absorptions (cm -1 ) are listed. The 1 H-NMR spectra were recorded on a Bruker AC-300 MHz FT-NMR using TMS as the internal standard (chemical shifts in d value).
From the structure-activity relationship, it was found that compounds 1a, 1b, 2c, 3a, 3c and 3d show moderate antitubercular activity against Mycobacterium tuberculosis strain H 37 Rv. In the case of antimicrobial activity, compounds 1c, 2d, 3d were found to be active against E. coli, while 1b, 3c showed moderate activity against P. vulgaris and compounds 2d, 1d and 3b were active against B-megaterium. Compounds 1a, 1b, 1d, 2b, 2c, 3a and 3b showed prominent activity against S. aureus.
Preparation of N-(3-phenoxy-a-piperidin-1-ylbenzyl)acetamide (1a)
To an aqueous solution of acetamide (0.075 mol, 4.42 g), piperidine (0.05 mol, 4.25 g) was added and stirred to obtain clear solution. 3-Phenoxybenzaldehyde (0.05 mol, 9.9 g) was then added dropwise and the mixture was stirred for 2 h in an ice-bath. The resulting colloidal solution was kept at room temperature for about a week with occasional stirring. The precipitate was isolated by vacuum filtration and recrystallized from methanol. 9 .96 (1H, s, -NH), 7.02-7.85 (10H, m, Ar-H). The mass spectrum indicated the molecular ion peak at m/z 324.
The reaction procedure leading to 1a was then extended to the syntheses of 1b-1d. The physical data of the obtained compounds are listed in Table I . 
Preparation of 1,3-bis-(3-phenoxy-a-piperidin-1-ylbenzyl]urea (2a)
To an aqueous solution of urea (0.1 mol, 6.0 g in 20 ml of water), ice-cooled piperidine (0.05 mol, 4.25 g) was added and stirred for 30 min. 3-Phenoxybenzaldehyde (0.05 mol, 9.9 g) was then added and the mixture was stirred for 2 h, at 5 ºC in an ice-bath and left for one day at room temperature. The resulting solid was isolated and crystallized from methanol. The reaction procedure leading to 2a was then extended to the syntheses of 2b, 2c and 2d. The physical data of the obtained compounds 2a-d are listed in Table I .
Preparation of 1,3-bis-(3-phenoxy-a-piperidin-1-ylbenzyl)thiourea (3a)
A mixture of thiourea (0.1 mol, 7.6 g), piperidine (0.05 mol, 4.25 g) and water (20 ml) was stirred to obtain a clear solution. To this ice-cold solution, 3-phenoxybenzaldehyde (0.05 mol, 9.9 g) was added. The reaction procedure leading to 3a was then extended to the syntheses of 3b, 3c and 3d. The physical data of the obtained compounds 3a-d are listed in Table I .
RESULTS AND DISCUSSION
Antitubercular activity. All the compounds were screened against Mycobacterium tuberculosis strain H 37 Rv at a concentration 6.25 mg/ml in BACTEC 12B medium using BACTEC 460-radiometric system. The standard drug used was rifampin. It could be observed that compounds 1a, 1b, 2c, 3c and 3d had higher activity than the standard. The screening results are given in Table II . Antimicrobial activity. The antimicrobial activity was assayed using the cup-plate agar diffusion method 11 by measuring the zone of inhibition in mm. All the compounds were screened in vitro for their antimicrobial activity against a variety of bacterial strains, i.e., Bacillus megaterium, Escherichia coli, Proteus vulgaris, Staphylococcus aureus, and the fungi Aspergillus niger at a concentration of 40 mg/ml. Standard drugs, i.e., amoxycillin, benzyl penicillin, ciprofloxacin, erythromycin and griseofulvin, were used for comparison purposes (Table II) . It can be observed that compounds 1c, 1d and 3d were active against E. coli; compounds 1c, 2a and 3c were active against P. vulgaris; compounds 1b, 2c and 2a were active against B. megaterium; compounds 1a, 1b, 2b, 2c, 3a and 3b were active against S. aureus and compounds 1a, 1c, 1d, 2b, 3a and 3c displayed maximum activity against A. niger.
